Phenylalanine

Phenylalanine

SCHEMBL1675409

NC(=O)CC[C@H](N)C(=O)O.N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.73
ALPI P09923 1/20 0.73
PKM P14618 1/20 0.73
PTGS1 P23219 1/20 0.73
XIAP P98170 1/20 0.73
ALOX15 P16050 1/20 0.63
BLM P54132 1/20 0.63
PMP22 Q01453 1/20 0.63
KMT2A Q03164 1/20 0.63
SLC1A3 P43003 2/20 0.54
SLC1A2 P43004 2/20 0.54
SLC1A1 P43005 2/20 0.54
SLC15A1 P46059 1/20 0.54
LTA4H P09960 2/20 0.51
NOS3 P29474 3/20 0.50
NOS1 P29475 3/20 0.50
NOS2 P35228 3/20 0.50
TPH1 P17752 2/20 0.50
PTPN1 P18031 1/20 0.50
GRIA2 P42262 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Phenylalanine SCHEMBL3630630 1.00 SLC7A5 (0.73) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL10428543 0.94 SLC7A5 (0.65) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL21905169 0.94 SLC7A5 (0.65) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL10428542 0.94 SLC7A5 (0.65) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL792008 0.94 SLC7A5 (0.65) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL28495410 0.94 SLC7A5 (0.65) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL4287332 0.93 SLC7A5 (0.63) SLC7A5ALPIPKMPTGS1XIAP
Tyrosine SCHEMBL21097842 0.93 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL27597221 0.89 SLC7A5 (0.58) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL28638756 0.88 SLC7A5 (0.61) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117054657-B Combined blocking agent and application thereof in latex immunoturbidimetry detection 北京豪迈生物工程股份有限公司 2024-04-02 CN claimed
CN-117054657-A Combined blocking agent and application thereof in latex immunoturbidimetry detection 北京豪迈生物工程股份有限公司 2023-11-14 CN claimed
CN-108267580-A A kind of active group using specific dipeptides inhibits the immunoturbidimetry reagent of IgM types RF interference 南京天纵易康生物科技股份有限公司 2018-07-10 CN claimed
CN-104450614-B The immunocyte serum free medium and its application method in a kind of animal protein-free source 上海安集协康生物技术股份有限公司 2017-07-07 CN claimed
US-20130078732-A1 METHODS FOR DIAGNOSING IMPENDING JOINT FAILURE GUFFEY WENDELL RAY (US) 2013-03-28 US claimed
EP-2391889-A2 METHODS FOR DIAGNOSING IMPENDING JOINT FAILURE Nestec S.A. (CH) 2011-12-07 EP claimed
WO-2010087991-A2 METHODS FOR DIAGNOSING IMPENDING JOINT FAILURE NESTEC S.A. (CH) 2010-08-05 WO claimed
US-20030104389-A1 Synthesis of biologically active compounds in cells SERGEEV PAVEL (CH) 2003-06-05 US claimed
EP-1208219-A1 SYNTHESIS OF BIOLOGICALLY ACTIVE COMPOUNDS IN CELLS Sergeev, Pavel (CH) 2002-05-29 EP claimed
WO-2000061775-A1 SYNTHESIS OF BIOLOGICALLY ACTIVE COMPOUNDS IN CELLS SERGEEV PAVEL (CH) 2000-10-19 WO claimed
WO-1996032127-A1 METHODS OF ENHANCING EPITHELIAL CELL PROLIFERATION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1996-10-17 WO claimed
EP-0281418-B1 Process for production of physiologically active peptide containing cysteine residue SUNTORY LTD (JP) 1995-01-11 EP claimed
EP-0281418-A2 Process for production of physiologically active peptide containing cysteine residue SUNTORY LIMITED (JP) 1988-09-07 EP claimed
EP-3650540-B9 TARGET-SPECIFIC CRISPR MUTANT TOOLGEN INC (KR) 2026-02-18 EP disclosed
US-20250290054-A1 TARGET-SPECIFIC CRISPR MUTANT TOOLGEN INCORPORATED (KR) 2025-09-18 US disclosed
US-12351838-B2 Target-specific CRISPR mutant TOOLGEN INCORPORATED (KR) 2025-07-08 US disclosed
EP-0458167-A1 Fatty acid-pulmonary surfactant conjugates ABBOTT LABORATORIES (US) 1991-11-27 EP disclosed
EP-0413957-A2 Pulmonary surfactant protein fragments ABBOTT LABORATORIES (US) 1991-02-27 EP disclosed
EP-0134307-B1 PREACTIVATED SURFACES OF SYNTHETIC MATERIALS FOR IMMOBILIZING ORGANOCHEMICAL AND BIOLOGICAL SUBSTANCES, PROCESS FOR PREPARING THEM AND THEIR USE Henning Berlin GmbH Chemie und Pharmawerk (DE) 1989-04-19 EP disclosed
EP-0206037-A2 Carbamates and ureas of N-(2-aminoacylamido-2-desoxy-hexosyl) amide, method for their preparation and their pharmaceutical use BAYER AG (DE) 1986-12-30 EP disclosed